World

Top 946 largest Companies in the Biotechnology industry in the World by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry in the world by market capitalization with links to their reference stock.

World Biotechnology Industry Analysis
World Top Companies World Companies Analysis

Top Biotechnology Companies in the World as of Jan. 01, 2026

Rank Company Market Cap (USD) Country Sector Industry
271 Ambrx Biopharma, Inc. $878.1 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
272 Xiangxue Pharmaceutical Co.,Ltd. $856.9 M China Chinese Healthcare Chinese Biotechnology
273 Oneness Biotech Co. Ltd $856.8 M Taiwan Taiwanese Healthcare Taiwanese Biotechnology
274 Ocumension Therapeutics $847.9 M China Chinese Healthcare Chinese Biotechnology
275 Geron Corporation $842.6 M United States US Healthcare US Biotechnology
276 Arvinas, Inc. $842.1 M United States US Healthcare US Biotechnology
277 Vir Biotechnology, Inc. $826.4 M United States US Healthcare US Biotechnology
278 Mesoblast Limited $816.3 M

(July 1, 2024)

 Australia Australian Healthcare Australian Biotechnology
279 Jacobio Pharmaceuticals Group Co. Ltd $806.0 M China Chinese Healthcare Chinese Biotechnology
280 Avid Bioservices, Inc. $796.3 M

(Jan. 1, 2025)

 United States US Healthcare US Biotechnology
281 ORIC Pharmaceuticals, Inc. $795.7 M United States US Healthcare US Biotechnology
282 Intercept Pharmaceuticals, Inc. $794.7 M

(Nov. 1, 2023)

 United States US Healthcare US Biotechnology
283 Aquestive Therapeutics, Inc. $786.9 M United States US Healthcare US Biotechnology
284 KalVista Pharmaceuticals, Inc. $781.4 M United States US Healthcare US Biotechnology
285 DBV Technologies SA $769.5 M France French Healthcare French Biotechnology
286 Valneva SE $769.4 M France French Healthcare French Biotechnology
287 GlycoMimetics, Inc. $764.8 M United States US Healthcare US Biotechnology
288 Rigel Pharmaceuticals, Inc. $759.3 M United States US Healthcare US Biotechnology
289 CTI BioPharma Corp. $737.3 M

(Jan. 1, 2023)

 United States US Healthcare US Biotechnology
290 Fulcrum Therapeutics, Inc. $720.4 M United States US Healthcare US Biotechnology
291 CytomX Therapeutics, Inc. $720.1 M United States US Healthcare US Biotechnology
292 Chempartner Pharmatech Co. Ltd $717.6 M China Chinese Healthcare Chinese Biotechnology
293 Zhejiang Orient Gene Biotech Co. Ltd $707.8 M China Chinese Healthcare Chinese Biotechnology
294 Annexon, Inc. $699.1 M United States US Healthcare US Biotechnology
295 Sunmax Biotechnology Co. Ltd $698.9 M Taiwan Taiwanese Healthcare Taiwanese Biotechnology
296 Replimune Group, Inc. $698.1 M United States US Healthcare US Biotechnology
297 GuiZhou SanLi Pharmaceutical Co. Ltd $687.8 M China Chinese Healthcare Chinese Biotechnology
298 REGENXBIO Inc. $687.0 M United States US Healthcare US Biotechnology
299 Takara Bio, Inc. $669.3 M Japan Japanese Healthcare Japanese Biotechnology
300 Gossamer Bio, Inc. $666.6 M United States US Healthcare US Biotechnology

Top Biotechnology Companies in the World as of Jan. 01, 2026

271. Ambrx Biopharma, Inc.

Company Profile: Ambrx Biopharma, Inc.
Market Cap (USD): $878.1 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

272. Xiangxue Pharmaceutical Co.,Ltd.

Company Profile: Xiangxue Pharmaceutical Co.,Ltd.
Market Cap (USD): $856.9 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

273. Oneness Biotech Co. Ltd

Company Profile: Oneness Biotech Co. Ltd
Market Cap (USD): $856.8 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Biotechnology

274. Ocumension Therapeutics

Company Profile: Ocumension Therapeutics
Market Cap (USD): $847.9 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

275. Geron Corporation

Company Profile: Geron Corporation
Market Cap (USD): $842.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

276. Arvinas, Inc.

Company Profile: Arvinas, Inc.
Market Cap (USD): $842.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

277. Vir Biotechnology, Inc.

Company Profile: Vir Biotechnology, Inc.
Market Cap (USD): $826.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

278. Mesoblast Limited

Company Profile: Mesoblast Limited
Market Cap (USD): $816.3 M (July 1, 2024)
Country: Australia
Sector: Australian Healthcare
Industry: Australian Biotechnology

279. Jacobio Pharmaceuticals Group Co. Ltd

Company Profile: Jacobio Pharmaceuticals Group Co. Ltd
Market Cap (USD): $806.0 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

280. Avid Bioservices, Inc.

Company Profile: Avid Bioservices, Inc.
Market Cap (USD): $796.3 M (Jan. 1, 2025)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

281. ORIC Pharmaceuticals, Inc.

Company Profile: ORIC Pharmaceuticals, Inc.
Market Cap (USD): $795.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

282. Intercept Pharmaceuticals, Inc.

Company Profile: Intercept Pharmaceuticals, Inc.
Market Cap (USD): $794.7 M (Nov. 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

283. Aquestive Therapeutics, Inc.

Company Profile: Aquestive Therapeutics, Inc.
Market Cap (USD): $786.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

284. KalVista Pharmaceuticals, Inc.

Company Profile: KalVista Pharmaceuticals, Inc.
Market Cap (USD): $781.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

285. DBV Technologies SA

Company Profile: DBV Technologies SA
Market Cap (USD): $769.5 M
Country: France
Sector: French Healthcare
Industry: French Biotechnology

286. Valneva SE

Company Profile: Valneva SE
Market Cap (USD): $769.4 M
Country: France
Sector: French Healthcare
Industry: French Biotechnology

287. GlycoMimetics, Inc.

Company Profile: GlycoMimetics, Inc.
Market Cap (USD): $764.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

288. Rigel Pharmaceuticals, Inc.

Company Profile: Rigel Pharmaceuticals, Inc.
Market Cap (USD): $759.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

289. CTI BioPharma Corp.

Company Profile: CTI BioPharma Corp.
Market Cap (USD): $737.3 M (Jan. 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

290. Fulcrum Therapeutics, Inc.

Company Profile: Fulcrum Therapeutics, Inc.
Market Cap (USD): $720.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

291. CytomX Therapeutics, Inc.

Company Profile: CytomX Therapeutics, Inc.
Market Cap (USD): $720.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

292. Chempartner Pharmatech Co. Ltd

Company Profile: Chempartner Pharmatech Co. Ltd
Market Cap (USD): $717.6 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

293. Zhejiang Orient Gene Biotech Co. Ltd

Company Profile: Zhejiang Orient Gene Biotech Co. Ltd
Market Cap (USD): $707.8 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

294. Annexon, Inc.

Company Profile: Annexon, Inc.
Market Cap (USD): $699.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

295. Sunmax Biotechnology Co. Ltd

Company Profile: Sunmax Biotechnology Co. Ltd
Market Cap (USD): $698.9 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Biotechnology

296. Replimune Group, Inc.

Company Profile: Replimune Group, Inc.
Market Cap (USD): $698.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

297. GuiZhou SanLi Pharmaceutical Co. Ltd

Company Profile: GuiZhou SanLi Pharmaceutical Co. Ltd
Market Cap (USD): $687.8 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

298. REGENXBIO Inc.

Company Profile: REGENXBIO Inc.
Market Cap (USD): $687.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

299. Takara Bio, Inc.

Company Profile: Takara Bio, Inc.
Market Cap (USD): $669.3 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Biotechnology

300. Gossamer Bio, Inc.

Company Profile: Gossamer Bio, Inc.
Market Cap (USD): $666.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

Stay in touch